Titan Biotech (BOM:524717) Short-Term Capital Lease Obligation : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Titan Biotech Short-Term Capital Lease Obligation?

Titan Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil.

Titan Biotech's quarterly Short-Term Capital Lease Obligation increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹4 Mil) but then declined from Sep. 2024 (₹4 Mil) to Dec. 2024 (₹0 Mil).

Titan Biotech's annual Short-Term Capital Lease Obligation increased from Mar. 2022 (₹3 Mil) to Mar. 2023 (₹4 Mil) and increased from Mar. 2023 (₹4 Mil) to Mar. 2024 (₹4 Mil).

Titan Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Titan Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Biotech Short-Term Capital Lease Obligation Chart

Titan Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.50

2.90

3.81

4.38

Titan Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	4.38	-	4.05	-

Titan Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Titan Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Titan Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Titan Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Biotech Ltd (BOM:524717) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi, IND, 110034

Website

https://www.titanbiotechltd.com

Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.

Titan Biotech Headlines

No Headlines